• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Thyroid dysfunction not associated with cognitive decline

byJake EngelandMichael Pratte
September 10, 2021
in Chronic Disease, Endocrinology, Psychiatry
Reading Time: 2 mins read
Share on FacebookShare on Twitter

1. This retrospective, multicohort study demonstrated no cross-sectional or longitudinal associations between thyroid dysfunction and global cognition, memory, executive function, or dementia.

Evidence Rating Level: 2 (Good)

Study Rundown: Current clinical guidelines suggest that thyroid dysfunction is a treatable and reversible cause of cognitive decline and dementia. However, observational studies have demonstrated mixed results on whether there is a definite association. This retrospective, multicohort, observational study examined the cross-sectional and longitudinal associations between thyroid dysfunction and cognitive decline. Participants were divided into five groups: overt hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, overt hypothyroidism, and euthyroidism (reference standard). The primary outcome was global cognitive function, using one of several verified cognitive scales. Upon cross-sectional and longitudinal assessments, there were no associations between thyroid dysfunction and cognitive test scores (global cognition, executive function, and memory). Notably, subclinical hypothyroidism had better performances in executive function (standardized mean difference: 0.07 [95% CI: 0.01-0.13]; p= 0.03) and memory (standardized mean difference: 0.08 [95% CI: 0.01-0.15]; p= 0.03) than those who were euthyroid. Furthermore, there was no longitudinal association found between thyroid dysfunction and the development of dementia. The hazard ratios for the development of dementia were 1.54 (95% CI: 0.76-3.10) and 0.79 (95% CI: 0.48-1.28) for overt hyperthyroidism and overt hypothyroidism, respectively. Overall, this study demonstrated a lack of association between cognition and thyroid dysfunction. One limitation of this study, however, is that many individuals receive treatment for thyroid dysfunction; therefore, further investigation is required to determine if untreated thyroid dysfunction in the long term is associated with cognitive decline.

Click to read the study in JAMA Internal Medicine

Relevant Reading: Subclinical thyroid dysfunction and the risk of cognitive decline: a meta-analysis of prospective cohort studies

Image: PD

RELATED REPORTS

Older married couples demonstrate domain-specific cognitive concordance 

A cognitive rehabilitation program may improve cognitive performance in patients with long COVID

A multimodal approach combining cognitive assessment with biomarkers may accurately predict dementia risk

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cognitive declineHyperthyroidismHypothyroidismmild cognitive impairment (MCI)thyroid
Previous Post

#VisualAbstract Dupilumab may contribute to ocular surface disease in patients with atopic dermatitis

Next Post

2 Minute Medicine Rewind September 13, 2021 

RelatedReports

Neurology

Older married couples demonstrate domain-specific cognitive concordance 

August 28, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

A cognitive rehabilitation program may improve cognitive performance in patients with long COVID

July 28, 2026
Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine
Chronic Disease

A multimodal approach combining cognitive assessment with biomarkers may accurately predict dementia risk

May 19, 2026
Patient Basics: Graves’ Disease
Career Development

What Is the Cricothyroid Membrane and Why It Matters in Medicine

September 17, 2025
Next Post

2 Minute Medicine Rewind September 13, 2021 

Matching patients to therapists based on clinical compatibility improved mental health

Mental retardation associated with IVF treatment

Use of in vitro fertilization, twin pregnancies and advanced maternal age independently associated with adverse maternal outcomes

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.